Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students

Douglas Cullinan, Kenneth D. Gadow, Michael H Epstein

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Psychotropic drug treatment in learning-disabled (LD), educable mentally retarded (EMR), and seriously emotionally disturbed (ED) children and adolescents receiving public school special education services was examined. The findings indicated that while treatment prevalence rates for EMR and ED groups were comparable, the rate for LD students was much lower. In the LD sample, pharmacotherapy was associated with higher ratings of behavioral deviance, longer placement in special education, less social integration, and greater peer rejection, which suggests that symptom severity is an important determiner of pharmacotherapy in this population.

Original languageEnglish (US)
Pages (from-to)469-477
Number of pages9
JournalJournal of Abnormal Child Psychology
Volume15
Issue number4
DOIs
StatePublished - Dec 1 1987

Fingerprint

Psychotropic Drugs
Mentally Disabled Persons
Special Education
Learning
Students
Drug Therapy
Therapeutics
Population

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students. / Cullinan, Douglas; Gadow, Kenneth D.; Epstein, Michael H.

In: Journal of Abnormal Child Psychology, Vol. 15, No. 4, 01.12.1987, p. 469-477.

Research output: Contribution to journalArticle

@article{575024b3ccac42aa9e530b98352422b5,
title = "Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students",
abstract = "Psychotropic drug treatment in learning-disabled (LD), educable mentally retarded (EMR), and seriously emotionally disturbed (ED) children and adolescents receiving public school special education services was examined. The findings indicated that while treatment prevalence rates for EMR and ED groups were comparable, the rate for LD students was much lower. In the LD sample, pharmacotherapy was associated with higher ratings of behavioral deviance, longer placement in special education, less social integration, and greater peer rejection, which suggests that symptom severity is an important determiner of pharmacotherapy in this population.",
author = "Douglas Cullinan and Gadow, {Kenneth D.} and Epstein, {Michael H}",
year = "1987",
month = "12",
day = "1",
doi = "10.1007/BF00917234",
language = "English (US)",
volume = "15",
pages = "469--477",
journal = "Journal of Abnormal Child Psychology",
issn = "0091-0627",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students

AU - Cullinan, Douglas

AU - Gadow, Kenneth D.

AU - Epstein, Michael H

PY - 1987/12/1

Y1 - 1987/12/1

N2 - Psychotropic drug treatment in learning-disabled (LD), educable mentally retarded (EMR), and seriously emotionally disturbed (ED) children and adolescents receiving public school special education services was examined. The findings indicated that while treatment prevalence rates for EMR and ED groups were comparable, the rate for LD students was much lower. In the LD sample, pharmacotherapy was associated with higher ratings of behavioral deviance, longer placement in special education, less social integration, and greater peer rejection, which suggests that symptom severity is an important determiner of pharmacotherapy in this population.

AB - Psychotropic drug treatment in learning-disabled (LD), educable mentally retarded (EMR), and seriously emotionally disturbed (ED) children and adolescents receiving public school special education services was examined. The findings indicated that while treatment prevalence rates for EMR and ED groups were comparable, the rate for LD students was much lower. In the LD sample, pharmacotherapy was associated with higher ratings of behavioral deviance, longer placement in special education, less social integration, and greater peer rejection, which suggests that symptom severity is an important determiner of pharmacotherapy in this population.

UR - http://www.scopus.com/inward/record.url?scp=0023832589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023832589&partnerID=8YFLogxK

U2 - 10.1007/BF00917234

DO - 10.1007/BF00917234

M3 - Article

VL - 15

SP - 469

EP - 477

JO - Journal of Abnormal Child Psychology

JF - Journal of Abnormal Child Psychology

SN - 0091-0627

IS - 4

ER -